«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:

期数:

2023年4期

页码:

88-91

栏目:

出版日期:

2023-04-10

文章信息/Info

Title:

Effi cacy Analysis of Luohuazizhu Tablet Combined with Hydroxychloroquine in the Treatment of Erythema Capillary Dilated Rosacea

文章编号:

1008-6455（2023）04-0088-04

作者:

刘 萍; 姚 倩; 徐 琳; 瓦庆彪; 何 梅; 龚亚莉; 刘立凡

(成都市第二人民医院皮肤科 四川 成都 610000)

Author(s):

LIU Ping; YAO Qian; XU Lin; WA Qingbiao; HE Mei; GONG Yali; LIU Lifan

(Department of Dermatology,Chengdu Second People’s Hospital,Chengdu 610000,Sichuan,China)

关键词:

红斑毛细血管扩张型玫瑰痤疮; 裸花紫珠片; 羟氯喹; 疗效; 美学效果

Keywords:

erythema capillary dilatation rosacea;  Luohuazizhu tablet;  hydroxychloroquine;  curative eff ect;  aesthetic eff ect

分类号:

R758.73+ 3

文献标志码:

A

摘要:

目的：探究裸花紫珠片结合羟氯喹治疗红斑毛细血管扩张型玫瑰痤疮的疗效。方法：纳入2019年6月-2021年6月笔者 医院收治的109例红斑毛细血管扩张型玫瑰痤疮患者为研究对象，以随机数字表法分为对照组（55例）和观察组（54例）， 对照组采取羟氯喹治疗，观察组采取裸花紫珠片联合羟氯喹治疗。观察两组疗效、毛细血管扩张缓解时间、红斑好转时间、 皮肤敏感及潮红好转时间，观察患者主客观症状评分、美学效果评分及皮肤红斑指数E值、血清白介素-37（IL-37）水平变 化，采用痤疮特异性生活质量问卷（Acne-QoL）评估患者生活质量，并观察不良反应发生情况。结果：治疗后，观察组疗效 优于对照组，且患者毛细血管扩张缓解时间、红斑好转时间、皮肤敏感好转时间及皮肤潮红好转时间短于对照组，差异均有 统计学意义（P＜0.05）；观察组治疗后主观、客观症状评分显著低于对照组（P＜0.05），治疗后患者美学效果评分均升 高，皮肤红斑指数E值、IL-37水平均降低，观察组改善水平优于对照组，差异均有统计学意义（P＜0.05）；两组Acne-QOL 评分均改善，观察组优于对照组（P＜0.05），两组不良反应均较少，差异无统计学意义（P＞0.05）。结论：红斑毛细血管 扩张型玫瑰痤疮患者采用裸花紫珠片结合羟氯喹治疗效果显著，美学效果佳，安全可靠，值得临床推广应用。

Abstract:

Objective To explore the effi cacy of Luohuazizhu tablets combined with hydroxychloroquine in the treatment of erythema capillary dilated rosacea. Methods In this study, 109 patients with erythema telangiectasis rosacea admitted to the author’s hospital from June 2019 to June 2021 were divided into control group (55 cases) and observation group (54 cases) by random number table method. The control group was treated with hydroxychloroquine, and the observation group was treated with Luohuazizhu tablets combined with hydroxychloroquine. To observe the curative eff ect, capillary expansion relief time, sensitive skin erythema turnaround time, turnaround time, skin fl ush turnaround time, patient subjective symptom scores and objective symptom scores, beauty rating changes and skin erythema index E value change, serum interleukin-37 (IL 37) level changes, acne specifi c quality of life questionnaire (Acne-QoL) score and adverse reactions in the observation and control groups. Results Observation group of patients curative eff ect was better than the control group after treatment, and patients with capillary expansion relief time, sensitive skin erythema turnaround time, turnaround time and improved skin fl ush time shorter than the control group(P ＜0.05). After treatment, the subjective and objective symptom scores of patients in the observation group were signifi cantly lower than those of patients in the control group(P ＜0.05),the beauty rating in both groups increased, and the skin erythema index E value and IL-37 levels decreased in both groups,with the observation group showing better improvement than the control group,the diff erences were statistically signifi cant(P ＜0.05). The Acne-QoL scores had improved in both groups, with the observation group scoring signifi cantly higher than the control group,the diff erences were statistically signifi cant(P ＜0.05). There were few adverse reactions in both groups(P＞0.05). Conclusion The treatment of erythema telangiectasia rosacea with Luohuazizhu tablets in combination with hydroxychloroquine has obvious effi cacy, good aesthetic eff ect, safety and reliability, and is worthy of application.

常用功能

更新日期/Last Update: 2023-05-09